this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
• Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
BIO News


Saturday, November 07, 2009

Primer

Click here for a printer-friendly page Printer Friendly YES
How are gene patents different from patents on other chemical structures?

There is no legal distinction between a gene patent and patents on other chemicals. Every gene (including complementary DNA, or cDNA forms) is a molecule that can be defined as a specific chemical structure (see "What is a gene?"). Other molecules that are not genes but have beneficial medical effects have been patented. They too are often defined by their chemical structure. Two examples include:

  • Aspirin - a compound whose chemical name is salicylic acid acetate (2-(acetyloxy)benzoic acid). Felix Hoffmann patented it in 1900.
  • Beta-Carotene - (U.S. Patent 5,871,766 [1999]) a compound that was defined by its chemical structure.

contact us | terms of use | privacy policy
© 2009 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024